FLIC
Bloomberg
Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO
Attovia Therapeutics Inc., an early-stage drug developer focused on immune-mediated diseases with high unmet need, is seeking to raise as much as $212.5 million in a US initial public offering.
1 vote cast by the community
FLIC Trust Score70 / 100
How FLIC Trust Scores workFLIC Trust Scores turn community ratings into a 0–100 signal about how readers assess a story. Fake News votes lower the score, while Liberal, Conservative, and Independent classifications support it. The formula also rewards a balanced split between Liberal and Conservative ratings instead of treating one political viewpoint as automatically more trustworthy. Scores can change as more people vote and represent community judgment, not a factual verdict or substitute for reading the original reporting. Learn more about how FLIC works.
Open in FLIC App
or
Continue on Web